mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.1 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |